Trick or treat: The role of vaccines in integrated schistosomiasis control

PLoS Neglected Tropical Diseases

Volumn 2, Issue 6, 2008, Pages

  Bergquist, Robert ^a   Utzinger, Jürg ^b   McManus, Donald P ^c  

^a Swiss Tropical Institute ^*  (Sweden)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BILHVAX; FATTY ACID BINDING PROTEIN; GLUTATHIONE TRANSFERASE; PRAZIQUANTEL; SCHISTOSOMA VACCINE; TETRASPANIN; TETRASPANIN 1; TETRASPANIN 2; PARASITE ANTIGEN; PROTOZOAL VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG RESEARCH; DRUG SYNTHESIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFECTION CONTROL; NONHUMAN; RESOURCE ALLOCATION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; VACCINATION; ANIMAL; IMMUNOLOGY; METHODOLOGY; QUALITY ADJUSTED LIFE YEAR;

ANIMALS; ANTIGENS, HELMINTH; COMMUNICABLE DISEASE CONTROL; HUMANS; PROTOZOAN VACCINES; QUALITY-ADJUSTED LIFE YEARS; SCHISTOSOMIASIS;

EID: 48949118085     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000244     Document Type: Article

References (38)

1. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related out-comes in endemic schistosomiasis. Lancet 365: 1561-1569.
2. Steinmann P, Keiser J, Bos; R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development systematic review, meta-analysis, and estimates ofpcople at risk. Lancet Infect Dis 6: 411-425.
3. Hotez PJ, Molyneux DH, Fenwick A, Kumaresen J, Ehrlich Sachs S, et al. (2007) Control of neglected tropical diseascs. N Engl J Med 357: 101B-1027.
4. Utzinger J, Bergquist R, Xiao SH, Sin BH, Tanner M (2003) Sustainable schistosomiasis control-the way forward. Lancet 362: 1932-1934.
5. Singer BH, Castro MC (2007) Bridges to sustainable tropical health. Proc Natl Acad Sci USA 104: 16038-16043.
6. King CH, Sturrock RF, Kariuki HC, Hamburger J (2006) Transmission control for schistosomissis-why it matters now. Trends Parasitol 22: 575-582.
7. Bergquist NR, Leonardo LR, Mitchell GF (2005) Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 21: 112-117.
8. Colley DG, Secor WE (2007) A schistosomiasis research agenda. PLoS Negl Trop Dis 1: e32. doi:10.1371/journal.pntd.0000032.
9. Bethony JM, Loukas A (2008) The schistosomiasis research agenda-what now? PLoS Negl Trop Dis 2: e207. doi:10.1371/journal.pntd.0000207.
10. Mathers CD, Ezzati M, Lopez AD (2007) Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 1: e114. doi:10.1371/journalpntd.0000114.
11. Stein C, Kuchenmüller T, Hendrickx S, Prüss Ustiin A, Wolfson L, et al. (2007) The global burden of disease assessment-WHO is responsible? PLoS Negl Trop Dis 1: e116. doi: 10.1371/ journal.pntd.0000116.
12. WHO/TDR (2008) Funding and resouroes. Available: http://www.who.int/tdr/ about/resources/. Accessed 27 May 2008.
13. Jia TW, Zhou XN, Wang XH, Utzinger J, Steinmann P, et al. (2007) Assessment of the age-specific disability weight of chronic schistosomiasis japonica. Bull World Health Organ 85: 458-465.
14. King CH, Bertino AM (2008) Asymmetries of poverty: why global burden of disease valuations significantly underestimate the burden of neglected tropical diseases. PLoS Negl Trop Dis 2: e209. doi: 10.1371/ journal.pntd.0000209.
15. Singer BH, Ryff CD (2007) Neglected tropical diseases, neglected data sources, and neglected issues. PLoS Negl Trop Dis 1: e104. doi: 10.1371/ journal.pntd.0000104.
16. Olveda RM, Daniel BL, Ramirez BD, Aligui GD, Acosta LP, et al. (1996) Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity. J Infect Dis 174: 163-172.
17. The PLoS Medicine Editors (2008) The neglected tropical diseases section in PLoS Medicine: moving beyond tropical infections. PLoS Med 5: e59. doi:10.1371/journal.pmed.0050059.
18. Office of the Press Secretary (20 Febiruary 2008) Fact sheet: fighting neglected tropical diseases around the world [press release]. Available: http://www.whitehouse.gov/news/releases/2008/02/20080220.html. Accessed 3 June 2008.
19. Butterworth AE, Capron M, Cordingley JS, Dalton PR, Dunne DW, et al. (1985) Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Trans R Soc Trop Med Hyg 79: 393-408.
20. Correa-Oliveira R, Caldas IR, Gazzinelli G (2000) Natural versus drug-induced resistance in Shistasoma mansoni infection. Parasitol Today 16: 397-399.
21. Dean DA (1983) Schistosoma and related genera: acquired resistance in mice. Exp Parasitol 55: 1-104.
22. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Rev Microbiol 21: 225-242.
23. Lightowlers MW (2006) Cestode vaccines: origins, current status and future prospects. Parasitology 133 (Suppl). S27-S42.
24. Bergquist NR, Colley DG (1998) Schistosomiasis vaccine: research to development. Parasitol Today 14: 99-104.
25. Tendler M, Simpson AJG (2008) The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine. Acta Trop, In press.
26. Capron A, Riveau G, Capron M, Trottein F (2005) Schistosomes: the road from host-parasite interactions to vaccines in dinical trials. Trends Parasitol 21: 143-149.
27. van der Werf MJ, de Vlas SJ, Brooker S, Looman CWN, Nagelkerke NJD, et al. (2003) Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acts. Trop 86: 125-139.
28. Utzinger J, Zhou XN, Chen MG, Bergquist R (2005) Conquering schistosomiasis in China: die long march. Acta Trop 96: 69-96.
29. McManus DP (2005) Prospects for development of a transmission blocking vaccine against Schistosoma japonicum. Parasite Immunol 27: 297-308.
30. Gray DJ, Williams GM, Li YS, Chen HG, Li RS, et al. (2007) A cluster-randomized bovine intervention trial against Schistosoma japonicum in the People's Republic of China: design and baseline resuits. Am J Trop Med Hyg 77: 866-874.
31. Wu XH, Wang XH, Utzinger J, Kun Y, Kristensen TK, et al. (2007) Spatio-temporal correlation between human and bovine schistosomiasis in China: insight from three nationwide surveys. Geospatial Health 2: 75-84.
32. Hu W, Yan Q, Shen DK, Liu F, Zhu ZD, et al. (2003) Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource. Nat Genet 35: 139-147.
33. Verjovski-Almeida S, DeMarco R, Martins EA, Guimaraes PE, Ojopi EP, et al. (2003) Transcriptome analysis of the aceolomate human parasite Schistosoma mansoni. Nat Genet 35: 148-157.
34. Wilson RA, Ashton PD, Braschi S, Dillon GP, Berriman M, et al. (2007) 'Oming in on schistosomes: prospects and limitations for post genomics. Trends Parasitol 23: 14-20.
35. Al-Sherbiny M, Osman A, Barakat R, El Morshedy H, Bergquist R, et al. (2003) In vitro cellular and humoral responses to Schistosoma mansoni vaccine candidate antigens. Acta Trop 88: 117-130.
36. Acosta LP, Waine G, Aligui GD, Tin WU, Olveda RM, et al. (2002) Immune correlate study on human Schistosoma japanicum in a well-defined population in Leyte, Philippines: II. Cellular immune responses to S. japonicum recombinant and native antigens. Acta Trop 84, 137-149.
37. Tran MH, Pearson MS, Bethony JM, Smyth DJ, Jones MK, et al. (2006) Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nat Med 12: 835-840.
38. Gryseels B (2000) Schistosomiasis vaccines: a devils' advocate view. Parasitol Today 16: 46-48.